Scientifically, great progress has been made in understanding how Alzheimer’s changes the brain, Penn Medicine physician Jason Karlawish told a 2016 Penn Alumni-Faculty Exchange audience. But despite research findings that suggest potential new approaches, there have been no dramatic changes in either the diagnostics or therapies currently available for the brain destroying disease.
Karlawish, MD, Co-Director of the Penn Memory Center, Director of Penn’s Neurodegenerative Disease Ethics and Policy Program (NDEP), and a Senior Fellow at the Leonard Davis Institute of Health Economics (LDI), was one of a number of top Penn experts taking part in April’s day-long series of health research-related presentations for the 50th anniversary gathering of the Penn Class of 1966.